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Introduction
Hemoglobin, which gives blood its red color, is perhaps the
most recognized and well studied protein in nature. It is also a
critical molecule during infection, as many microbes rely on
hemoglobin to grow within their hosts. Here, we review the
importance of hemoglobin to vertebrate physiology and how
humans attempt to conceal hemoglobin from invading pathogens.
We also provide examples of the elaborate mechanisms employed
by microbes to acquire hemoglobin during infection. Finally, we
discuss how genetic variations within hemoglobin affect suscepti-
bility to infectious diseases.
Hemoglobin Metabolism within Humans
To understand how hemoglobin is utilized by invading
pathogens, one must understand the structure, function, and
metabolism of this molecule. Hemoglobin is a tetrameric globular
protein consisting of two alpha and two beta chains [1]. The alpha
and beta chains are encoded by different loci and are differentially
regulated during human development. Each of the four chains of
hemoglobin encloses an iron-containing heme co-factor responsi-
ble for oxygen binding [2]. The main function of hemoglobin is to
capture atmospheric oxygen and deliver it to host tissues for
respiration. Hemoglobin is synthesized in developing red blood
cells, which lose their nuclei and cease protein synthesis upon
maturation. In healthy adults, hemoglobin constitutes one-third of
total erythrocyte mass and approximately 15% of the whole blood
mass [2]. Mature erythrocytes circulate in the blood for
approximately three months, whereupon they become senescent
and are removed from the bloodstream by macrophages.
Hemoglobin from senescent erythrocytes is digested to facilitate
the recycling of heme-iron. In the case of erythrocyte lysis,
liberated hemoglobin is captured by the plasma protein hapto-
globin to prevent oxidative damage inflicted by hemoglobin. The
haptoglobin-hemoglobin complex is recognized by macrophages
and removed from the plasma. Any free heme that is released from
hemoglobin extracellularly is rapidly bound by another plasma
protein known as hemopexin. The above strategies for hemoglobin
and heme removal limit the toxicity associated with these
molecules, ensure iron homeostasis, and prevent microbial growth.
Hemoglobin as a Source of Iron to Invading
Pathogens
Iron is an essential nutrient for virtually all forms of life.
Hemoglobin, being by far the most abundant reservoir of iron
within humans, is thus an attractive nutrient iron source for
invading pathogens. In keeping with this, numerous bacterial
species have evolved systems to extract iron from host hemoglobin
[3]. These systems are energetically costly and are targeted by the
immune system; therefore, they are only expressed under iron-
limiting conditions. In order to release hemoglobin from red blood
cells, bacteria secrete toxins that lyse erythrocytes. Released
hemoglobin is then bound by specific receptors that are either
secreted or anchored to the cell surface of the bacteria. Upon
binding of hemoglobin, these receptors remove the heme moiety
from hemoglobin and pass it to heme transport proteins within the
cell surface (Figure 1A and 1B). To transfer heme across the
Gram-negative outer membrane, heme transport systems utilize
the energy of the proton motive force. This is achieved through the
TonB system, which transfers energy from the inner to the outer
membrane to enable substrate transport. Once in the periplasm,
heme is bound by a heme transport protein that delivers heme to
the inner membrane ABC transporter, which pumps heme into
the cytoplasm (Figure 1A) [4]. Gram-positive bacteria, which lack
an outer membrane but contain a thick cell wall, bind and pass
heme through the cell wall in a relay process with no known
energy requirement (Figure 1B). Upon crossing the Gram-positive
cell wall, heme is transported through the cell membrane by ABC
transporters. Once in the cytoplasm of either Gram-negative or
Gram-positive bacteria, heme is degraded by heme oxygenases to
release iron (Figure 1A and 1B). Alternatively, intact heme can be
incorporated into bacterial heme-containing proteins in a process
known as molecular hijacking [5]. Bacteria are not unique in their
ability to utilize hemoglobin as an iron source. Eukaryotic
pathogens, including Leishmania, Entamoeba, and Trypanosoma, have
evolved convergent mechanisms of heme-iron acquisition from
this abundant host molecule [6–8]. Protozoa capture hemoglobin
through either specific surface receptors or phagocytosis. Upon
phagocytosis, the protein portion of hemoglobin is digested to
release heme-iron [7]. The utilization of hemoglobin as an iron
source is required for infection as demonstrated by a decrease in
virulence of pathogens that are mutated for hemoglobin-iron
transporters. Therefore, surface hemoglobin receptors have been
studied as potential targets for vaccine development and
pharmacological inhibition. Impeding a pathogen’s ability to
acquire iron would inhibit numerous physiological processes that
are essential for viability, providing a novel avenue for antimicro-
bial development.
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PLoS Pathogens | www.plospathogens.org 1 March 2012 | Volume 8 | Issue 3 | e1002535Figure 1. Mechanisms of hemoglobin utilization by pathogens. (A) Gram-negative bacteria bind hemoglobin by either secreted or surface
receptors. Hemoglobin receptors extract heme and pass it to heme transport proteins within the cell surface. Outer membrane heme transport
systems utilize the energy of the proton motive force generated within the inner membrane by the TonB complex. Once in the periplasm, heme is
bound by a heme transport protein, which delivers heme to the inner membrane ABC transporter. ABC transporters pass heme into the cytoplasm,
where it is degraded by heme oxygenases to supply the bacterium with iron. (B) Gram-positive bacteria express secreted and cell wall–anchored
hemoglobin receptors that extract heme from hemoglobin. Hemoglobin receptors then transfer heme to the cell wall transporters that pass heme
through the peptidoglycan layer in a relay process. Heme is then transported across the cell membrane by ABC transporters. In the cytoplasm, heme
is degraded by heme oxygenases to release iron. (C) Plasmodium consumes hemoglobin by endocytosis of pockets of red blood cell cytoplasm
through cytostomes, which transfer hemoglobin to digestive vacuoles. Hemoglobin is sequentially digested by proteases and aminopeptidases in the
digestive vacuole and cytoplasm to supply Plasmodium with amino acids. The released heme is polymerized into hemozoin.
doi:10.1371/journal.ppat.1002535.g001
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Invading Pathogens
While many microorganisms target hemoglobin to acquire
heme-iron, others, such as Plasmodium, digest the protein as a
source of amino acids. Plasmodium is a genus of parasitic protists
and the causative agent of the disease malaria. Hemoglobin plays a
central role during the blood stage of Plasmodium infections.
Following invasion of erythrocytes, these parasites consume more
than half of the cellular hemoglobin within a 24-hour period [9].
This hemoglobin consumption is achieved through several distinct
mechanisms. During the initial stage of erythrocyte infection,
known as the ring stage, hemoglobin is taken up by a single large
vacuole in an actin-independent process known as a ‘‘big gulp’’
[10]. At a later trophozoit stage, hemoglobin is acquired by
endocytosis of pockets of erythrocyte cytoplasm within parasite
structures known as cytostomes. (Figure 1C) [9,11]. Cytosomes
then transfer hemoglobin to acidic digestive vacuoles in an actin-
dependent process that is regulated by Rab5 and PfPI3K proteins
[10,12]. Late-stage parasites ingest hemoglobin through phago-
trophy, which, similar to the ‘‘big gulp’’, does not require actin and
involves large vacuoles [10,13]. Hemoglobin is sequentially
digested by aspartic proteases, cysteine proteases, metallopro-
teases, and aminopeptidases in the digestive vacuole and
cytoplasm of Plasmodium to supply the parasite with amino acids
[14]. Digestion of hemoglobin has been suggested to be initiated
en route to the digestive vacuole; however, the exact localization of
different stages of this process is not uniformly agreed upon [15].
The critical importance of hemoglobin digestion is illustrated by
the fact that blocking hemoglobin proteolysis prevents parasite
development [9]. Inhibitors of hemoglobin proteases have been
suggested as potential therapeutic agents against parasites that
utilize hemoglobin as a source of amino acids.
Coping with Hemoglobin Toxicity
Hemoglobin utilization leads to the release of the reactive heme co-
factor from the globin portion of the protein. In Plasmodium,fr e eh e me
is detoxified by polymerization into crystals known as hemozoin
(Figure 1C). In fact, hemozoin formation is so abundant that its
presence within Anopheles gambiae mosquitoes provided the initial clue
that mosquitoes are the primary vector of malaria transmission [9].
Hemozoin formation during chronic infection manifests itself in the
blackening of the spleen and liver due to the accumulation of
hemozoin within these organs. Further, hemozoin appears to play a
role in modulating the immune response to Plasmodium and is toxic to
phagocytes [9]. Hemozoin crystals are generated by polymerization
of heme through the formation of a bond between the iron atom of
one heme molecule and carboxylate of another [16]. Dimers further
polymerize through the formation of hydrogen bonds between
propionates [17]. The factors that contribute to the formation of
hemozoin have been the subject of considerable debate; however,
lipids and proteins have been implicated in facilitating hemozoin
formation within the digestive vacuoles of Plasmodium [18]. Antima-
larial drugs such as chloroquine and possibly artemisinin inhibit
hemoglobin detoxification by Plasmodium, underscoring the impor-
tance of this process for malarial viability [19,20].
Bacterial pathogens utilize various strategies to reduce the toxic
effects of heme. One mechanism is somewhat similar to the one
utilized by Plasmodium whereby heme is actively sequestered by
Gram-negative bacteria, thus preventing generation of reactive
oxygen species [21]. Other bacterial species utilize heme
oxygenases, which reduce the intracellular heme concentration
through its degradation [3]. Yet other bacterial pathogens sense
either heme or its toxic effects and up-regulate ATP-dependent
export systems involved in heme detoxification. It is not clear
whether heme itself or an unknown toxic product generated by
heme is being exported; however, it is evident that both the sensing
and transport components are required for heme detoxification
[22].
Human Hemoglobin Variants and Infection
Sequence variations within the hemoglobin genes profoundly
influence susceptibility to infectious diseases. In this regard,
hemoglobin variants have been associated with altered suscepti-
bility to Plasmodium. For example, individuals who are heterozy-
gous for the hemoglobin mutation that leads to sickle cell anemia
(HbS) show increased resistance to malaria. HbS contains a
glutamine to valine substitution within the beta chain of hem-
oglobin. In individuals that are homozygous for HbS, hemoglobin
molecules aggregate within the erythrocytes, resulting in sickling of
red blood cells and severe anemia. Heterozygous individuals are
not anemic and eliminate up to 90% of Plasmodium cells within
their erythrocytes. Numerous mechanisms have been suggested for
decreased survival of Plasmodium due to HbS [23]. These include
reduced growth of the parasite, increased sickling, and enhanced
phagocytosis of infected erythrocytes. Recent studies attribute
protection provided by HbS to a reduction in actin remodeling
and cytoadherence of infected erythrocytes to capillaries, and a
decrease in heme toxicity [24–26]. Sickle cell hemoglobin is
prevalent in individuals from regions where malaria is endemic,
which has created evolutionary pressure to maintain the allele
within the population [27]. Other mutations resulting in
hemoglobinopathies have also been found to protect against
Plasmodium [23]. Altered susceptibility to malaria due to mutations
within hemoglobin is the paradigm for how human genetics
impact susceptibility to infectious diseases.
Numerous non-pathologic hemoglobin polymorphisms are
found within the human population and may impact bacterial
iron acquisition and virulence. This is supported by the finding
that variations within the amino acid sequence of hemoglobin
derived from different mammals affect iron acquisition and
virulence of the bacterial pathogen Staphylococcus aureus [28]. A
recent co-crystal structure of hemoglobin with a staphylococcal
hemoglobin receptor has revealed that the region of hemoglobin
recognized by this receptor is highly polymorphic within the
human population. Amino acid variations in this region of
hemoglobin reduce binding and utilization of hemoglobin by S.
aureus [29]. Therefore, the susceptibility of individuals to bacterial
infections may be affected by hemoglobin polymorphisms.
Further, bacterial colonization may similarly be affected due to
the fact that hemoglobin plays a role in this process [30]. Future
identification of hemoglobin polymorphisms that influence
bacterial infections may enable a personalized approach to the
prevention and treatment of infectious diseases.
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